Canada markets closed

Pasithea Therapeutics Corp. (KTTAW)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.0140+0.0015 (+12.00%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
Total Revenue
260.909
0
0
15.062
Cost of Revenue
131.778
-
113.195
17.275
Gross Profit
129.131
-
373.364
-2.213
Operating Expenses
Research Development
8,101
8,101
2,665
0
Selling General and Administrative
10,542
7,879
9,924
4,505
Total Operating Expenses
11,821
15,979
12,589
4,505
Operating Income or Loss
-11,692
-15,979
-12,589
-4,507
Interest Expense
-
-
0.102
0.508
Total Other Income/Expenses Net
3,504
56.245
861.086
2,334
Income Before Tax
-8,189
-15,508
-11,728
-2,174
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-8,189
-15,508
-11,728
-2,174
Net Income
-8,189
-15,962
-13,936
-2,174
Net Income available to common shareholders
-8,189
-15,962
-13,936
-2,174